Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
US5021416A · kind A · utility
64Cited by
1References
28Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 31, 1989 |
| Grant date | Jun 4, 1991 |
| Priority date | — |
| Expiry date | Oct 31, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain (2-imidazolin-2-ylamino) quinoxalines are disclosed. Such quinoxalines reduce or maintain intraocular pressure when administered directly to the eye of a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.